14
Views
9
CrossRef citations to date
0
Altmetric
Original

Heroin treatment demand in South Africa: trends from two large metropolitan sites (January 1997–December 2003)

, , , , , , , & show all
Pages 419-423 | Received 22 Sep 2004, Accepted 18 Mar 2005, Published online: 12 Jul 2009

References

  • United Nations Office on Drugs and Crime. Global illicit drug trends: 2004. United Nations Office on Drugs and Crime, New York 2004
  • Man L -H, Best D, Gossop M, Noble A, Strang J. Risk of overdose: do those who witness most overdoses also experience most overdoses?. J Subst Use 2002; 7: 136–140
  • Mientjies G H, Spijkerman I J, van Ameijden E J, Coutinho R A, van den Hoek A. Incidence and risk factors for pneumonia in HIV infected and noninfected drug users. J Infect 1996; 32: 181–186
  • Fernandez H. Heroin. Hazelden, Minnesota 1998; 19–67
  • Diamantis I, Bassetti S, Erb P, Ladewig D, Gyr K, Battegay M. High prevalence and coinfection rate of hepatitis G and C infections in intravenous drug addicts. J Hepatol 1997; 26: 794–797
  • Koester S, Booth R E, Zhang Y. The prevalence of additional injection-related HIV risk behaviours among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 22: 202–207
  • Sanchez J, Comerford M, Chitwood D D, Fernandez M I, McCoy C B. High risk sexual behaviours among heroin sniffers who have no history of injection drug use: implications for HIV risk education. AIDS Care 2001; 14: 391–398
  • Morentin B, Callado L F, Meana J J. Differences in criminal activity between heroin abusers and subjects without psychiatric disorders—analysis of 578 detainees in Bilbao, Spain. J Forensic Sci 1998; 3: 993–999
  • National Institute of Justice. Research report. 2000 Annual report on opiate use among arrestees. US Department of Justice, Washington 2001; 3–24
  • United Nations Office for Drug Control and Crime Prevention. Global illicit drug trends: 2002. United Nations Office of Drug Control and Crime Prevention Studies on Drugs and Crime, New York 2002
  • Shisana O, Zungu-Dirwayi N, Toefy Y, Simbayi L. Substance use and HIV in South Africa: results from a household survey. Paper presented at the NIDA meeting, Collaboration across continents: drug abuse, health disparities, HIV and other health-related research. Cape Town July, 2003
  • Statistics South Africa. The people of South Africa: population census, 2001. Census in brief. Statistics South Africa, Pretoria 2003
  • Shisana O, Simbayi L. South African national HIV prevalence, behavioural risks and mass media household survey 2002. Human Sciences Research Council, Cape Town 2002
  • UNAIDS. UNAIDS 2004 report on the global AIDS epidemic. UNAIDS, Geneva 2004
  • Parry C DH, Bhana A, Myers B, et al. The South African Community Epidemiology Network on Drug Use (SACENDU): description, findings (1997–1999) and policy implications. Addiction 2002; 97: 969–976
  • Myers B, Parry C DH. Report on audit of substance abuse treatment facilities in Cape Town (2002). Medical Research Council, Cape Town 2003
  • Myers B. Technical report on audit of substance abuse treatment facilities in Gauteng (2003–2004). Medical Research Council, Cape Town 2004
  • Community Epidemiology Work Group, NIDA. Epidemiologic trends in drug abuse. Division of Epidemiology, Services and Prevention Research, NIH, Bethesda, MD June, 2001; Volume I, Highlights and executive summary
  • Australian Institute for Mental Health and Welfare. Substance users at alcohol and other drug treatment services 2001–2002. 2003, available at: www.aihw.gov.au
  • Myers B, Parry C DH, Plüddemann A. Indicators of substance abuse treatment demand in Cape Town, South Africa (1997–2001). Curationis 2004; 27: 27–31
  • Community Epidemiology Work Group, NIDA. Epidemiologic trends in drug abuse. Division of Epidemiology, Services and Prevention Research, NIH, Bethesda, MD 2002; Volume I, Highlights and executive summary, June 2002
  • Ross J, Cohen J, Darke S, Hando J, Hall W. Transitions between routes of administration and correlates of injecting amongst regular amphetamine users. National Drug and Alcohol Research Centre, Sydney 1994

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.